JOHNSON KENNETH ERLAND

Insider profile

JOHNSON KENNETH ERLAND's trades of Xeris Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2020-02-18 2020-02-14 B Purchase
86,184 -26.6%
378.74
US$4,207,994
86,184 -26.6% 378.74 US$4,207,994
2019-02-25 2019-02-19 B Purchase
56,710 +48.3%
282.60
US$1,460,245
56,710 +48.3% 282.60 US$1,460,245